Study of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate Cancer
Public ClinicalTrials.gov record NCT03646162. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Double-blind, Placebo Controlled, Dose Finding Phase 2 Study Comparing Oral Daily Dosing of VERU-944 to Ameliorate the Vasomotor Symptoms Resulting From ADT in Men With Advanced Prostate Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Randomized, double-blind, placebo controlled, dose finding Phase 2 study comparing oral daily dosing of VERU-944 after a week of loading (daily dosing) with placebo to ameliorate the vasomotor symptoms resulting from androgen deprivation therapy in men with advanced prostate cancer
Study identification
- NCT ID
- NCT03646162
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 93 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 13, 2018
- Primary completion
- Apr 29, 2020
- Completion
- Oct 14, 2020
- Last update posted
- Dec 2, 2021
2018 – 2020
United States locations
- U.S. sites
- 24
- U.S. states
- 14
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Gen1 Research | Glendale | Arizona | 85308 | — |
| Tower Urology | Los Angeles | California | 90048 | — |
| Urology of San Bernardino | San Bernardino | California | 92404 | — |
| The Urology Center of Colorado | Denver | Colorado | 80211 | — |
| Foothills Urology | Golden | Colorado | 80401 | — |
| Universal Axon Clinical Research | Doral | Florida | 33166 | — |
| Medical Research Center | Miami | Florida | 33144 | — |
| North Idaho Urology | Coeur d'Alene | Idaho | 83814 | — |
| First Urology | Jeffersonville | Indiana | 47130 | — |
| Regional Urology LLC | Shreveport | Louisiana | 71101 | — |
| Chesapeake Urology | Towson | Maryland | 21204 | — |
| Coastal Urology | Brick | New Jersey | 08724 | — |
| Premier Urology Group | Edison | New Jersey | 08837 | — |
| Advance Urology | Elmont | New York | 11003 | — |
| AccuMed Research | Garden City | New York | 11530 | — |
| Premier Medical Group of the Hudson Valley | Poughkeepsie | New York | 12601 | — |
| Associated Medical Professionals | Syracuse | New York | 13210 | — |
| Clinical Research Solutions | Middleburg Heights | Ohio | 44130 | — |
| Urologic Consultants | Bala-Cynwyd | Pennsylvania | 19004 | — |
| Mary Crowley Cancer Research | Dallas | Texas | 75230 | — |
| Urology Clinics of North Texas | Dallas | Texas | 75231 | — |
| Houston Urology Partners | Houston | Texas | 77091 | — |
| Urology San Antonio | San Antonio | Texas | 78229 | — |
| Urology of Virginia | Virginia Beach | Virginia | 23462 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03646162, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 2, 2021 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03646162 live on ClinicalTrials.gov.